Back to Search Start Over

Management of Hepatic Granulomatous Tuberculosis After BCG Therapy for Bladder Cancer

Authors :
Mohsen Ayati
Mohammad Reza Nowroozi
Afshin Mortazavi
Solmaz Ohadian Moghadam
Hossein Ghorani
Source :
Urology Case Reports, Vol 13, Iss C, Pp 158-159 (2017)
Publication Year :
2017
Publisher :
Elsevier, 2017.

Abstract

BCG therapy is used as a treatment in bladder cancer. Intravesical administration of Bacillus Calmette-Guérin is used as a treatment method in superficial bladder cancer. While it is commonly effective, some serious side effects may occur. We hereby report a 65-year-old man who developed granulomatous hepatitis as a complication following BCG therapy. He was treated successfully with antitubercular therapy and prednisolone.

Details

Language :
English
ISSN :
22144420
Volume :
13
Issue :
C
Database :
Directory of Open Access Journals
Journal :
Urology Case Reports
Publication Type :
Academic Journal
Accession number :
edsdoj.f256f00dea494480bea19dc0abc5ab7f
Document Type :
article
Full Text :
https://doi.org/10.1016/j.eucr.2017.04.011